PharmacyCodes



Ocusert Pilo-20 en es it fr

Ocusert Pilo-20 Brand names, Ocusert Pilo-20 Analogs

Ocusert Pilo-20 Brand Names Mixture

  • E-Pilo 1 Ophthalmic Solution (Epinephrine bitartrate + Pilocarpine hydrochloride)
  • E-Pilo 2 Ophthalmic Solution (Epinephrine bitartrate + Pilocarpine hydrochloride)
  • E-Pilo 4 Ophthalmic Solution (Epinephrine Bitartrate + Pilocarpine Hydrochloride)
  • E-Pilo 6 Ophthalmic Solution (Epinephrine Bitartrate + Pilocarpine Hydrochloride)
  • E-Pilo-1 Oph Soln (Epinephrine Bitartrate + Pilocarpine Hydrochloride)
  • E-Pilo-2 Oph Soln (Epinephrine Bitartrate + Pilocarpine Hydrochloride)
  • E-Pilo-4 Oph Soln (Epinephrine Bitartrate + Pilocarpine Hydrochloride)
  • E-Pilo-6 Oph Soln (Epinephrine Bitartrate + Pilocarpine Hydrochloride)
  • Timpilo 2 (Pilocarpine Hydrochloride + Timolol Maleate)
  • Timpilo 4 (Pilocarpine Hydrochloride + Timolol Maleate)

Ocusert Pilo-20 Chemical_Formula

C11H16N2O2

Ocusert Pilo-20 RX_link

http://www.rxlist.com/cgi/generic3/salagen.htm

Ocusert Pilo-20 fda sheet

Ocusert_Pilo-20 FDA

Ocusert Pilo-20 msds (material safety sheet)

Ocusert_Pilo-20 MSDS

Ocusert Pilo-20 Synthesis Reference

Preobrashenski et al., Ber. 66, 1187 (1933)

Ocusert Pilo-20 Molecular Weight

208.257 g/mol

Ocusert Pilo-20 Melting Point

34 oC

Ocusert Pilo-20 H2O Solubility

1000 mg/ml

Ocusert Pilo-20 State

Solid

Ocusert Pilo-20 LogP

1.02

Ocusert Pilo-20 Dosage Forms

Drops; Gel; Implant; Liquid; Solution

Ocusert Pilo-20 Indication

For the treatment of radiation-induced dry mouth (xerostomia) and symptoms of dry mouth in patients with Sjögrens syndrome.

Ocusert Pilo-20 Pharmacology

Pilocarpine is a choline ester miotic and a positively charged quaternary ammonium compound. Pilocarpine, in appropriate dosage, can increase secretion by the exocrine glands. The sweat, salivary, lacrimal, gastric, pancreatic, and intestinal glands and the mucous cells of the respiratory tract may be stimulated. When applied topically to the eye as a single dose it causes miosis, spasm of accommodation, and may cause a transitory rise in intraocular pressure followed by a more persistent fall. Dose-related smooth muscle stimulation of the intestinal tract may cause increased tone, increased motility, spasm, and tenesmus. Bronchial smooth muscle tone may increase. The tone and motility of urinary tract, gallbladder, and biliary duct smooth muscle may be enhanced. Pilocarpine may have paradoxical effects on the cardiovascular system. The expected effect of a muscarinic agonist is vasodepression, but administration of pilocarpine may produce hypertension after a brief episode of hypotension. Bradycardia and tachycardia have both been reported with use of pilocarpine.

Ocusert Pilo-20 Absorption

There was a decrease in the rate of absorption of pilocarpine from SALAGEN Tablets when taken with a high fat meal by 12 healthy male volunteers

Ocusert Pilo-20 side effects and Toxicity

No information avaliable

Ocusert Pilo-20 Patient Information

Patients should be informed that pilocarpine may cause visual disturbances, especially at night, that could impair their ability to drive safely.

If a patient sweats excessively while taking pilocarpine hydrochloride and cannot drink enough liquid, the patient should consult a physician. Dehydration may develop.

Ocusert Pilo-20 Organisms Affected

Humans and other mammals